本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Aura Biosciences, Inc.

6.95
+0.03000.43%
成交量:30.45萬
成交額:211.96萬
市值:7.19億
市盈率:-3.92
高:7.00
開:6.92
低:6.92
收:6.92
52周最高:9.54
52周最低:4.73
股本:1.03億
流通股本:7,991.55萬
量比:1.39
換手率:0.38%
股息:- -
股息率:- -
每股收益(TTM):-1.7726
每股收益(LYR):-1.7599
淨資產收益率:-53.49%
總資產收益率:-31.24%
市淨率:2.28
市盈率(LYR):-3.95

資料載入中...

2025/05/16

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/05/15

重要事件披露

Form 8-K - Current report
2025/05/15

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/04/16

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/04/16

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/04/02

重要事件披露

Form 8-K - Current report
2025/03/24

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2025/03/24

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2025/03/24

重要事件披露

Form 8-K - Current report
2025/02/19

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/02/19

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/02/19

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/02/19

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/01/21

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/01/21

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/11/18

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/11/14

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/14

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/13

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/11/13

重要事件披露

Form 8-K - Current report